{"gene":"GABRA1","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":2002,"finding":"The Ala322Asp (A322D) missense mutation in GABRA1 (encoding the GABAA receptor α1 subunit) causes reduced amplitude of GABA-activated currents in vitro compared to wildtype receptors, indicating loss-of-function of this inhibitory ligand-gated ion channel.","method":"In vitro electrophysiology (GABA-activated current recording in transfected cells expressing mutant vs. wildtype receptors)","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro functional assay with mutagenesis, single lab but clear electrophysiological readout establishing loss-of-function mechanism","pmids":["11992121"],"is_preprint":false},{"year":2009,"finding":"The PTC-generating frameshift mutation 975delC (S326fs328X) in GABRA1 leads to substantial reduction of mutant α1 mRNA via nonsense-mediated mRNA decay (NMD) requiring intact ribosomes and the NMD-essential factor hUPF-1. A minor fraction of mRNA escapes NMD and produces truncated mutant protein, which undergoes endoplasmic reticulum-associated degradation (ERAD) with enhanced association with molecular chaperones.","method":"Minigene NMD assay, ribosome inhibition, siRNA knockdown of hUPF-1, protein stability assay, molecular chaperone co-immunoprecipitation in neurons and non-neuronal cells","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (NMD reporter, ribosome inhibition, gene silencing, ERAD assay, chaperone association) in a single rigorous study","pmids":["19261879"],"is_preprint":false},{"year":2016,"finding":"Four selected GABRA1 mutations studied in the Xenopus laevis oocyte expression system revealed loss-of-function of the GABAA receptor, without a clear genotype-phenotype correlation.","method":"Two-electrode voltage clamp electrophysiology in Xenopus laevis oocytes expressing mutant GABRA1","journal":"Neurology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — functional electrophysiology in oocyte system, single lab, limited detail in abstract","pmids":["27521439"],"is_preprint":false},{"year":2019,"finding":"De novo GABRA1 mutations (P260S, L296S/W315L in transmembrane domains; R112Q, N115D in N-terminal GABA binding domain) cause reduced cell surface and total GABAA receptor expression, altered ER processing, impaired synaptic clustering, reduced GABAA receptor function, and decreased GABA binding potency in neuronal and non-neuronal cells.","method":"Next-generation sequencing, patch-clamp electrophysiology, surface biotinylation, immunofluorescence receptor clustering assay, flow cytometry in neuronal and non-neuronal cells","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (electrophysiology, surface expression, clustering, ER processing) in same study, single lab","pmids":["31056671"],"is_preprint":false},{"year":2019,"finding":"The de novo GABRA1 R214C variant decreases whole-cell GABA-evoked currents by reducing single-channel open time and reducing both surface and total GABAA receptor expression. Verapamil treatment for 24 h fully restored function of mutant receptors primarily by increasing channel open time, while diazepam and insulin only partially restored currents.","method":"Whole-cell, outside-out macro-patch, and single-channel patch-clamp recordings; surface biotinylation assay; western blot in HEK cells expressing wildtype or mutant α1","journal":"Molecular brain","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution in HEK cells with multiple orthogonal patch-clamp configurations plus biochemical surface expression assays, single lab","pmids":["31707987"],"is_preprint":false},{"year":2020,"finding":"A novel de novo GABRA1 variant p.(Ala332Val) in transmembrane domain helix 3 (TM3) leaves protein levels and cell surface trafficking unchanged but produces a significant left-shift of apparent GABA potency and changes in desensitization kinetics, as well as a left-shifted apparent diazepam potency in radioligand displacement assays — a gain-of-sensitivity (increased GABA potency) mechanism.","method":"Two-electrode voltage clamp electrophysiology, radioligand displacement assay, surface expression analysis in Xenopus oocytes or heterologous expression system","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous in vitro functional assays with multiple readouts, but single lab and single variant","pmids":["32047208"],"is_preprint":false},{"year":2020,"finding":"Loss of gabra1 in zebrafish (morpholino knockdown) results in hypomotility and reduced expression of other GABAA receptor subunits. Expression of wildtype human GABRA1 partially rescued the hypomotility phenotype, whereas the c.875C>T variant failed to rescue, demonstrating that this is a loss-of-function allele.","method":"Zebrafish morpholino knockdown, behavioral analysis (swim patterns), rescue experiment with wildtype vs. mutant human GABRA1 mRNA injection","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with behavioral readout and rescue experiment, two orthogonal approaches, single lab","pmids":["32205311"],"is_preprint":false},{"year":2021,"finding":"GABRA1 mutations associated with Dravet syndrome (L215P, R214C, V287I, R214H) cause defects in receptor gating as the common functional deficiency, with variant α1 subunits expressing well but being functionally impaired, indicating gating dysfunction rather than trafficking as the primary mechanism for α1 and β2 subunit Dravet variants.","method":"Patch-clamp electrophysiology, GABAA receptor biogenesis and trafficking assays in transfected cells","journal":"Brain communications","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — functional electrophysiology and biogenesis assays, single lab, abstracts do not detail full method depth","pmids":["34095830"],"is_preprint":false},{"year":2022,"finding":"The GABRA1 α1(T292S) variant significantly increases GABA-evoked whole-cell currents and shifts dose-response curve leftward, increasing single-channel open time and open probability, demonstrating a gain-of-function at T292. In contrast, α1(T292I) decreases GABA-evoked currents, shifts dose-response rightward with severely diminished maximum, and decreases single-channel open time — demonstrating that T292 is a critical residue controlling GABAA receptor channel gating and that mutations at this residue can cause opposite gain- or loss-of-function effects.","method":"Whole-cell and single-channel patch-clamp recordings in HEK293 cells expressing wildtype or mutant rat recombinant GABAARs; biochemical analysis","journal":"International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution in HEK293 cells with whole-cell and single-channel patch-clamp, multiple mutants tested with opposite phenotypes establishing mechanistic residue function","pmids":["35269865"],"is_preprint":false},{"year":2017,"finding":"Ethanol exposure reduces GABRA1 (α1 subunit) gene and protein expression in cultured cortical neurons through class I HDAC (HDAC1-3)-mediated histone deacetylation at the Gabra1 promoter. Pharmacological inhibition or knockdown of HDAC1-3 prevented ethanol-induced decreases in α1 expression. Targeted histone acetylation at the Gabra1 promoter using CRISPR dCas9-P300 prevented the decrease, while targeting P300 to a distant exon had no effect.","method":"CRISPR dCas9-P300 targeted histone acetylation, dCas9-KRAB repressor, HDAC inhibitor pharmacology, siRNA knockdown of HDAC1-3, qPCR and western blot in cultured cortical neurons","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (CRISPR epigenetic editing, pharmacology, genetic knockdown) in same study establishing promoter-level histone deacetylation mechanism","pmids":["28798030"],"is_preprint":false},{"year":2016,"finding":"In chronic heart failure rats, JNK activation (downstream of prostaglandin E2/EP3 receptor signaling) reduces GABRA1 (and GAD1) expression in the paraventricular nucleus (PVN). JNK inhibitor SP600125 normalized sympathoexcitation and restored GAD1 and GABRA1 expression, while EP1, EP2, and EP4 receptor antagonists had no effect. PTGER3 agonist activated JNK and downregulated GABRA1 in NG108 neuronal cells.","method":"In vivo PVN infusion of receptor agonists/antagonists and JNK inhibitor in CHF rats, quantitative RT-PCR, western blot, immunofluorescence, renal sympathetic nerve discharge recordings, cell-based assays in NG108 neuronal cells","journal":"Acta physiologica (Oxford, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo pharmacological epistasis with multiple receptor-specific antagonists plus in vitro cell confirmation, single lab","pmids":["27439062"],"is_preprint":false},{"year":2025,"finding":"Four clinical GABRA1 frameshift variants (K401fs, S326fs, V290fs, F272fs) — removing one to three transmembrane helices — all exhibit significantly reduced trafficking to the cell surface in HEK293T cells, resulting in essentially non-functional ion channels. They show ER retention and activate the unfolded protein response (UPR) to varying extents depending on which transmembrane domains are deleted, revealing overlapping yet distinct proteostasis impairment mechanisms.","method":"Surface trafficking assay, ER retention immunofluorescence, UPR activation assay, patch-clamp electrophysiology in HEK293T cells","journal":"bioRxiv : the preprint server for biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (trafficking, ER retention, UPR, electrophysiology) across four variants, single lab, preprint","pmids":["39651292"],"is_preprint":true},{"year":2024,"finding":"Loss of function of gabra1 in zebrafish (germline sa43718 nonsense allele) causes light-induced hypermotility (seizure-like behavior) and decreased mRNA expression of gabra2, gabra3, and gabra5. Proteomics revealed abnormal expression of proteins regulating synaptic vesicle fusion, vesicle transport, synapse development, and mitochondrial protein complexes.","method":"Germline zebrafish mutant (sa43718 allele), behavioral analysis, qRT-PCR, proteomics","journal":"Differentiation; research in biological diversity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with behavioral, transcriptional, and proteomic readouts, single lab","pmids":["38908344"],"is_preprint":false},{"year":2026,"finding":"4-Phenylbutyrate (PBA) increases both total and cell surface α1 (GABRA1) subunit expression for wildtype and A322D mutant subunits in HEK293T cells and in vivo in Gabra1+/A322D knockin mice (increased GABAA receptor expression in thalamus), identifying PBA-mediated proteostasis enhancement as a mechanism to rescue GABRA1 variant-associated receptor trafficking deficits.","method":"Flow cytometry, patch-clamp recordings, western blot, in silico structural modeling in HEK293T cells; in vivo thalamic GABAA receptor expression in Gabra1+/A322D knockin mice","journal":"bioRxiv : the preprint server for biology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — multiple orthogonal methods in vitro and in vivo, single lab, preprint only","pmids":["42239367"],"is_preprint":true},{"year":2011,"finding":"Ectopic overexpression of GABRA1 in colon cancer cell lines resulted in strong inhibition of cell growth, suggesting a functional role in regulating cell proliferation in a non-neuronal context.","method":"Ectopic overexpression in colon cancer cell lines, cell growth assay","journal":"International journal of oncology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single overexpression assay in cancer cell lines, single lab, no mechanistic pathway placement","pmids":["22038115"],"is_preprint":false}],"current_model":"GABRA1 encodes the α1 subunit of the GABAA receptor, a ligand-gated chloride channel mediating fast inhibitory neurotransmission; pathogenic mutations cause loss-of-function via reduced GABA-evoked currents (impaired channel gating or reduced single-channel open time), decreased cell surface expression through ER retention/ERAD and NMD of PTC-containing transcripts, or — for rare variants such as A332V — gain-of-sensitivity with increased GABA potency; transcription of GABRA1 is repressed by class I HDAC-mediated histone deacetylation at its promoter (e.g., downstream of ethanol or JNK/prostaglandin signaling), and multiple upstream miRNAs (miR-129-2-3p, miR-181a-5p, miR-502-3p) directly target GABRA1 mRNA to regulate its expression."},"narrative":{"mechanistic_narrative":"GABRA1 encodes the α1 subunit of the GABAA receptor, a ligand-gated chloride channel that mediates fast inhibitory neurotransmission, and its disruption produces epileptic phenotypes through multiple convergent loss-of-function mechanisms [PMID:11992121, PMID:32205311]. Disease-associated missense and frameshift variants impair receptor function by distinct routes: some directly disrupt channel gating—reducing single-channel open time and GABA-evoked current amplitude while the subunit still expresses and traffics normally [PMID:31707987, PMID:34095830]—while others reduce cell-surface and total receptor levels through altered ER processing, ER retention, ERAD, and unfolded protein response activation, with frameshift/PTC transcripts additionally subject to nonsense-mediated decay [PMID:19261879, PMID:31056671, PMID:39651292]. The transmembrane residue T292 is a critical determinant of gating, where different substitutions produce opposite gain- or loss-of-function effects [PMID:35269865], and rare variants such as A332V instead increase apparent GABA potency without altering trafficking, defining a gain-of-sensitivity mechanism [PMID:32047208]. Beyond mutation, GABRA1 expression is repressed at its promoter by class I HDAC-mediated histone deacetylation downstream of ethanol exposure, and by JNK signaling downstream of prostaglandin E2/EP3 receptor activation [PMID:28798030, PMID:27439062]. Proteostasis-directed small molecules including verapamil and 4-phenylbutyrate can restore trafficking and function of variant receptors [PMID:31707987, PMID:42239367]. In vivo, loss of gabra1 causes motor and seizure-like behavioral phenotypes and downregulation of other GABAA receptor subunits, confirming its role in coordinated inhibitory receptor function [PMID:32205311, PMID:38908344].","teleology":[{"year":2002,"claim":"Established that a GABRA1 missense mutation directly impairs the inhibitory channel, defining a loss-of-function disease mechanism at the level of receptor current.","evidence":"In vitro electrophysiology of GABA-activated currents in transfected cells expressing mutant vs. wildtype α1","pmids":["11992121"],"confidence":"High","gaps":["Single variant; did not distinguish gating defect from trafficking deficit","No in vivo confirmation"]},{"year":2009,"claim":"Showed that PTC-generating frameshift alleles are eliminated by NMD and that escaping truncated protein is degraded by ERAD, explaining how such variants cause haploinsufficiency rather than dominant-negative toxicity.","evidence":"Minigene NMD assay, ribosome inhibition, hUPF-1 siRNA knockdown, ERAD/chaperone co-IP in neuronal and non-neuronal cells","pmids":["19261879"],"confidence":"High","gaps":["Single frameshift variant studied","Did not quantify residual surface receptor in vivo"]},{"year":2016,"claim":"Tested multiple clinical variants in a common expression system, confirming loss-of-function as a recurrent theme but finding no clean genotype-phenotype correlation.","evidence":"Two-electrode voltage clamp in Xenopus oocytes","pmids":["27521439"],"confidence":"Medium","gaps":["Limited mechanistic resolution","No surface expression or gating discrimination reported"]},{"year":2019,"claim":"Resolved that distinct domains contribute to dysfunction—N-terminal binding-domain variants reduce GABA potency while transmembrane variants impair ER processing, surface expression, and synaptic clustering.","evidence":"Patch-clamp, surface biotinylation, clustering immunofluorescence, flow cytometry in neuronal and non-neuronal cells","pmids":["31056671"],"confidence":"High","gaps":["Did not isolate single-channel gating parameters for all variants","Synaptic effects inferred from clustering, not synaptic transmission"]},{"year":2019,"claim":"Demonstrated that a gating-class variant reducing single-channel open time can be pharmacologically rescued, providing a mechanistic rationale for proteostasis/channel-modulator therapy.","evidence":"Whole-cell, macro-patch, and single-channel patch-clamp plus surface biotinylation and western blot in HEK cells, with verapamil/diazepam/insulin treatment","pmids":["31707987"],"confidence":"High","gaps":["Rescue shown in HEK cells, not in neurons or in vivo","Single variant"]},{"year":2020,"claim":"Identified a gain-of-sensitivity mechanism, showing that a TM3 variant increases GABA potency without trafficking change, expanding the variant mechanism spectrum beyond loss-of-function.","evidence":"Two-electrode voltage clamp, radioligand displacement, surface expression analysis","pmids":["32047208"],"confidence":"Medium","gaps":["Single variant","In vivo consequence of increased potency not established"]},{"year":2020,"claim":"Provided in vivo validation that a clinical variant is a loss-of-function allele, since wildtype but not variant human GABRA1 rescued knockdown phenotypes.","evidence":"Zebrafish morpholino knockdown with behavioral analysis and wildtype/mutant rescue","pmids":["32205311"],"confidence":"Medium","gaps":["Morpholino knockdown subject to off-target concerns","Single variant tested in rescue"]},{"year":2021,"claim":"Established that for a set of Dravet-associated α1 variants gating dysfunction—not trafficking—is the common functional deficit, since variant subunits expressed well but were impaired.","evidence":"Patch-clamp and biogenesis/trafficking assays in transfected cells","pmids":["34095830"],"confidence":"Medium","gaps":["Method depth limited in report","Did not reconcile with trafficking-deficient variants from other studies"]},{"year":2022,"claim":"Pinpointed T292 as a critical gating residue by showing opposite gain- and loss-of-function effects of different substitutions on single-channel open time and probability.","evidence":"Whole-cell and single-channel patch-clamp in HEK293 cells expressing recombinant GABAARs","pmids":["35269865"],"confidence":"High","gaps":["Structural basis of opposite effects not directly resolved","Clinical correlation of T292 variants not established here"]},{"year":2025,"claim":"Linked frameshift variants removing transmembrane helices to ER retention and graded UPR activation, defining variant-specific proteostasis impairment as a mechanism of channel loss.","evidence":"Surface trafficking, ER retention immunofluorescence, UPR activation, patch-clamp in HEK293T cells (preprint)","pmids":["39651292"],"confidence":"Medium","gaps":["Preprint, not peer-reviewed","Conducted in non-neuronal HEK293T cells only"]},{"year":2017,"claim":"Defined a transcriptional/epigenetic regulatory axis showing that class I HDAC-mediated histone deacetylation at the Gabra1 promoter represses expression downstream of ethanol.","evidence":"CRISPR dCas9-P300/KRAB epigenetic editing, HDAC inhibitor pharmacology, HDAC1-3 siRNA, qPCR/western in cortical neurons","pmids":["28798030"],"confidence":"High","gaps":["Mechanism linking ethanol to HDAC recruitment not fully resolved","In vivo behavioral consequence not tested here"]},{"year":2016,"claim":"Showed that prostaglandin E2/EP3-driven JNK signaling downregulates GABRA1 in the paraventricular nucleus, linking receptor expression to sympathoexcitation in heart failure.","evidence":"In vivo PVN pharmacology with receptor-specific antagonists and JNK inhibitor, RT-PCR, western, nerve recordings, NG108 cell assays","pmids":["27439062"],"confidence":"Medium","gaps":["Direct transcriptional target of JNK at Gabra1 promoter not defined","Correlative expression changes"]},{"year":2024,"claim":"Provided germline genetic in vivo evidence that gabra1 loss causes seizure-like behavior and coordinately downregulates other GABAA subunits, with broad synaptic/proteomic remodeling.","evidence":"Germline zebrafish nonsense mutant, behavioral analysis, qRT-PCR, proteomics","pmids":["38908344"],"confidence":"Medium","gaps":["Proteomic changes are associative, not mechanistically dissected","Single model organism"]},{"year":2026,"claim":"Demonstrated that the proteostasis enhancer 4-phenylbutyrate restores surface expression of trafficking-deficient variant receptors in vitro and in a knockin mouse, supporting a therapeutic strategy.","evidence":"Flow cytometry, patch-clamp, western, in silico modeling in HEK293T cells; thalamic receptor expression in Gabra1+/A322D knockin mice (preprint)","pmids":["42239367"],"confidence":"Medium","gaps":["Preprint, not peer-reviewed","Functional/behavioral rescue in mice not established"]},{"year":null,"claim":"How the distinct variant classes (gating-impaired, trafficking-deficient, gain-of-sensitivity) map onto specific clinical phenotypes, and whether epigenetic/miRNA and proteostasis-directed interventions translate to in vivo seizure rescue, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified genotype-phenotype framework across variant mechanisms","Therapeutic rescue largely in vitro or preprint-stage","Non-neuronal proliferative role uncharacterized mechanistically"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,4,8]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,3,8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,4,11]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,3,11]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,6,12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4]}],"complexes":["GABAA receptor"],"partners":["GABRA2","GABRA3","GABRA5","GABRB2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P14867","full_name":"Gamma-aminobutyric acid receptor subunit alpha-1","aliases":["GABA(A) receptor subunit alpha-1","GABAAR subunit alpha-1"],"length_aa":456,"mass_kda":51.8,"function":"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by Gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:23909897, PubMed:25489750, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:29950725, PubMed:30602789). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the cell membrane down their electrochemical gradient (PubMed:23909897, PubMed:29950725, PubMed:30602789). Alpha-1/GABRA1-containing GABAARs are largely synaptic (By similarity). Chloride influx into the postsynaptic neuron following GABAAR opening decreases the neuron ability to generate a new action potential, thereby reducing nerve transmission (By similarity). GABAARs containing alpha-1 and beta-2 or -3 subunits exhibit synaptogenic activity; the gamma-2 subunit being necessary but not sufficient to induce rapid synaptic contacts formation (PubMed:23909897, PubMed:25489750). GABAARs function also as histamine receptor where histamine binds at the interface of two neighboring beta subunits and potentiates GABA response (By similarity). GABAARs containing alpha, beta and epsilon subunits also permit spontaneous chloride channel activity while preserving the structural information required for GABA-gated openings (By similarity). Alpha-1-mediated plasticity in the orbitofrontal cortex regulates context-dependent action selection (By similarity). Together with rho subunits, may also control neuronal and glial GABAergic transmission in the cerebellum (By similarity)","subcellular_location":"Postsynaptic cell membrane; Cell membrane; Cytoplasmic vesicle membrane","url":"https://www.uniprot.org/uniprotkb/P14867/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GABRA1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GABRA1","total_profiled":1310},"omim":[{"mim_id":"620465","title":"EPILEPSY, EARLY-ONSET, 3, WITH OR WITHOUT DEVELOPMENTAL DELAY; EPEO3","url":"https://www.omim.org/entry/620465"},{"mim_id":"619964","title":"DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES; DEDISB","url":"https://www.omim.org/entry/619964"},{"mim_id":"618559","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79; DEE79","url":"https://www.omim.org/entry/618559"},{"mim_id":"615744","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19; DEE19","url":"https://www.omim.org/entry/615744"},{"mim_id":"612849","title":"UBIQUITIN-SPECIFIC PEPTIDASE 46; USP46","url":"https://www.omim.org/entry/612849"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":52.4},{"tissue":"retina","ntpm":16.5}],"url":"https://www.proteinatlas.org/search/GABRA1"},"hgnc":{"alias_symbol":["EJM5"],"prev_symbol":[]},"alphafold":{"accession":"P14867","domains":[{"cath_id":"2.70.170.10","chopping":"48-248","consensus_level":"medium","plddt":94.642,"start":48,"end":248},{"cath_id":"1.20.58.390","chopping":"251-342_417-443","consensus_level":"high","plddt":93.8876,"start":251,"end":443}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P14867","model_url":"https://alphafold.ebi.ac.uk/files/AF-P14867-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P14867-F1-predicted_aligned_error_v6.png","plddt_mean":81.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GABRA1","jax_strain_url":"https://www.jax.org/strain/search?query=GABRA1"},"sequence":{"accession":"P14867","fasta_url":"https://rest.uniprot.org/uniprotkb/P14867.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P14867/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P14867"}},"corpus_meta":[{"pmid":"11992121","id":"PMC_11992121","title":"Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11992121","citation_count":461,"is_preprint":false},{"pmid":"24623842","id":"PMC_24623842","title":"GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.","date":"2014","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24623842","citation_count":209,"is_preprint":false},{"pmid":"27521439","id":"PMC_27521439","title":"Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies.","date":"2016","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27521439","citation_count":113,"is_preprint":false},{"pmid":"16792556","id":"PMC_16792556","title":"Association between GABRA1 and drinking behaviors in the collaborative study on the genetics of alcoholism sample.","date":"2006","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/16792556","citation_count":79,"is_preprint":false},{"pmid":"26918889","id":"PMC_26918889","title":"De novo GABRA1 mutations in Ohtahara and West syndromes.","date":"2016","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/26918889","citation_count":74,"is_preprint":false},{"pmid":"35718920","id":"PMC_35718920","title":"Molecular and clinical descriptions of patients with GABAA receptor gene variants (GABRA1, GABRB2, GABRB3, GABRG2): A cohort study, review of literature, and genotype-phenotype correlation.","date":"2022","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/35718920","citation_count":72,"is_preprint":false},{"pmid":"30417952","id":"PMC_30417952","title":"Chronic alcohol exposure induced gut microbiota dysbiosis and its correlations with neuropsychic behaviors and brain BDNF/Gabra1 changes in mice.","date":"2018","source":"BioFactors (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30417952","citation_count":67,"is_preprint":false},{"pmid":"19261879","id":"PMC_19261879","title":"Two molecular pathways (NMD and ERAD) contribute to a genetic epilepsy associated with the GABA(A) receptor GABRA1 PTC mutation, 975delC, S326fs328X.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19261879","citation_count":55,"is_preprint":false},{"pmid":"1330891","id":"PMC_1330891","title":"Confirmation of the localization of the human GABAA receptor alpha 1-subunit gene (GABRA1) to distal 5q by linkage analysis.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1330891","citation_count":45,"is_preprint":false},{"pmid":"34001135","id":"PMC_34001135","title":"Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1.","date":"2021","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34001135","citation_count":44,"is_preprint":false},{"pmid":"16530959","id":"PMC_16530959","title":"Genetic analysis of the GABRA1 gene in patients with essential tremor.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16530959","citation_count":44,"is_preprint":false},{"pmid":"16839746","id":"PMC_16839746","title":"Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy.","date":"2006","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/16839746","citation_count":39,"is_preprint":false},{"pmid":"14706423","id":"PMC_14706423","title":"Possible association between a haplotype of the GABA-A receptor alpha 1 subunit gene (GABRA1) and mood disorders.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/14706423","citation_count":38,"is_preprint":false},{"pmid":"31056671","id":"PMC_31056671","title":"Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.","date":"2019","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31056671","citation_count":37,"is_preprint":false},{"pmid":"34095830","id":"PMC_34095830","title":"Dravet syndrome-associated mutations in GABRA1, GABRB2 and GABRG2 define the genetic landscape of defects of GABAA receptors.","date":"2021","source":"Brain communications","url":"https://pubmed.ncbi.nlm.nih.gov/34095830","citation_count":35,"is_preprint":false},{"pmid":"26189305","id":"PMC_26189305","title":"ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population.","date":"2015","source":"Die Pharmazie","url":"https://pubmed.ncbi.nlm.nih.gov/26189305","citation_count":30,"is_preprint":false},{"pmid":"22038115","id":"PMC_22038115","title":"Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.","date":"2011","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22038115","citation_count":24,"is_preprint":false},{"pmid":"32047208","id":"PMC_32047208","title":"A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32047208","citation_count":23,"is_preprint":false},{"pmid":"28864462","id":"PMC_28864462","title":"Rapid whole-genome sequencing identifies a novel GABRA1 variant associated with West syndrome.","date":"2017","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/28864462","citation_count":23,"is_preprint":false},{"pmid":"28798030","id":"PMC_28798030","title":"Ethanol Exposure Regulates Gabra1 Expression via Histone Deacetylation at the Promoter in Cultured Cortical Neurons.","date":"2017","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/28798030","citation_count":20,"is_preprint":false},{"pmid":"34029007","id":"PMC_34029007","title":"Inhibition of microRNA-129-2-3p protects against refractory temporal lobe epilepsy by regulating GABRA1.","date":"2021","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/34029007","citation_count":19,"is_preprint":false},{"pmid":"34740144","id":"PMC_34740144","title":"GABRA1 and GABRA6 gene mutations in idiopathic generalized epilepsy patients.","date":"2021","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/34740144","citation_count":18,"is_preprint":false},{"pmid":"32205311","id":"PMC_32205311","title":"Abnormal expression of GABAA receptor subunits and hypomotility upon loss of gabra1 in zebrafish.","date":"2020","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/32205311","citation_count":18,"is_preprint":false},{"pmid":"38269327","id":"PMC_38269327","title":"De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects.","date":"2024","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/38269327","citation_count":17,"is_preprint":false},{"pmid":"15955415","id":"PMC_15955415","title":"Mutation screen of GABRA1, GABRB2 and GABRG2 genes in Japanese patients with absence seizures.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15955415","citation_count":17,"is_preprint":false},{"pmid":"31707987","id":"PMC_31707987","title":"Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy.","date":"2019","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/31707987","citation_count":15,"is_preprint":false},{"pmid":"35269865","id":"PMC_35269865","title":"Distinct Functional Alterations and Therapeutic Options of Two Pathological De Novo Variants of the T292 Residue of GABRA1 Identified in Children with Epileptic Encephalopathy and Neurodevelopmental Disorders.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35269865","citation_count":15,"is_preprint":false},{"pmid":"26249742","id":"PMC_26249742","title":"Polymorphism rs4263535 in GABRA1 intron 4 was related to deeper sedation by intravenous midazolam.","date":"2015","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/26249742","citation_count":14,"is_preprint":false},{"pmid":"27613244","id":"PMC_27613244","title":"Do the exome: A case of Williams-Beuren syndrome with severe epilepsy due to a truncating de novo variant in GABRA1.","date":"2016","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27613244","citation_count":14,"is_preprint":false},{"pmid":"14631097","id":"PMC_14631097","title":"Absence of GABRA1 Ala322Asp mutation in juvenile myoclonic epilepsy families from India.","date":"2003","source":"Journal of genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14631097","citation_count":12,"is_preprint":false},{"pmid":"16256272","id":"PMC_16256272","title":"Mutations in GABRA1, GABRA5, GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16256272","citation_count":12,"is_preprint":false},{"pmid":"28540321","id":"PMC_28540321","title":"Novel SCN1A and GABRA1 Gene Mutations With Diverse Phenotypic Features and the Question on the Existence of a Broader Spectrum of Dravet Syndrome.","date":"2017","source":"Child neurology open","url":"https://pubmed.ncbi.nlm.nih.gov/28540321","citation_count":10,"is_preprint":false},{"pmid":"37434477","id":"PMC_37434477","title":"Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variant.","date":"2023","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37434477","citation_count":10,"is_preprint":false},{"pmid":"27245092","id":"PMC_27245092","title":"Evaluating the Role of Genetic Variants on first-line antiepileptic drug response in North India: Significance of SCN1A and GABRA1 Gene Variants in Phenytoin Monotherapy and its Serum Drug Levels.","date":"2016","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/27245092","citation_count":10,"is_preprint":false},{"pmid":"37182675","id":"PMC_37182675","title":"Rhynchophylline inhibits methamphetamine dependence via modulating the miR-181a-5p/GABRA1 axis.","date":"2023","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37182675","citation_count":9,"is_preprint":false},{"pmid":"16569738","id":"PMC_16569738","title":"Allelic variants of the gamma-aminobutyric acid-A receptor alpha1-subunit gene (GABRA1) are not associated with idiopathic gonadotropin-dependent precocious puberty in girls with and without electroencephalographic abnormalities.","date":"2006","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16569738","citation_count":9,"is_preprint":false},{"pmid":"37809401","id":"PMC_37809401","title":"Pathogenic variants of human GABRA1 gene associated with epilepsy: A computational approach.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/37809401","citation_count":8,"is_preprint":false},{"pmid":"35173461","id":"PMC_35173461","title":"GABRA1 and GABRB2 Polymorphisms are Associated with Propofol Susceptibility.","date":"2022","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35173461","citation_count":8,"is_preprint":false},{"pmid":"35689264","id":"PMC_35689264","title":"Long non-coding RNA Gm37494 alleviates osteoarthritis chondrocyte injury via the microRNA-181a-5p/GABRA1 axis.","date":"2022","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/35689264","citation_count":7,"is_preprint":false},{"pmid":"27439062","id":"PMC_27439062","title":"c-Jun N-terminal Kinase mediates prostaglandin-induced sympathoexcitation in rats with chronic heart failure by reducing GAD1 and GABRA1 expression.","date":"2016","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27439062","citation_count":7,"is_preprint":false},{"pmid":"37703949","id":"PMC_37703949","title":"Epilepsy plus blindness in microdeletion of GABRA1 and GABRG2 in mouse and human.","date":"2023","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37703949","citation_count":5,"is_preprint":false},{"pmid":"35520951","id":"PMC_35520951","title":"Successful use of perampanel in GABRA1-related myoclonic epilepsy with photosensitivity.","date":"2022","source":"Epilepsy & behavior reports","url":"https://pubmed.ncbi.nlm.nih.gov/35520951","citation_count":5,"is_preprint":false},{"pmid":"38908344","id":"PMC_38908344","title":"Characterization of the zebrafish gabra1sa43718/sa43718 germline loss of function allele confirms a function for Gabra1 in motility and nervous system development.","date":"2024","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/38908344","citation_count":4,"is_preprint":false},{"pmid":"32102148","id":"PMC_32102148","title":"[Clinical phenotypes of epilepsy associated with GABRA1 gene variants].","date":"2020","source":"Zhonghua er ke za zhi = Chinese journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32102148","citation_count":4,"is_preprint":false},{"pmid":"39651292","id":"PMC_39651292","title":"GABRA1 frameshift variants impair GABAA receptor proteostasis.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39651292","citation_count":3,"is_preprint":false},{"pmid":"36584483","id":"PMC_36584483","title":"Genetic interaction between GABRA1 and ERBB4 variants in the pathogenesis of genetic generalized epilepsy.","date":"2022","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/36584483","citation_count":3,"is_preprint":false},{"pmid":"36747751","id":"PMC_36747751","title":"Characterization of the zebrafish gabra1 germline loss of function allele confirms a function for Gabra1 in motility and nervous system development.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36747751","citation_count":2,"is_preprint":false},{"pmid":"42239367","id":"PMC_42239367","title":"4-Phenylbutyrate Rescue in GABRA1 Variants Associated with Developmental Epileptic Encephalopathies: from Cell and Mouse Models to Human.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/42239367","citation_count":0,"is_preprint":false},{"pmid":"41643875","id":"PMC_41643875","title":"Porcine Cardiac Blood processed Kansui Radix alleviates PTZ-induced epileptic damage in mice via the bidirectional regulation of GABRA1 and cGMP/PKG signaling pathway.","date":"2026","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41643875","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.30.685505","title":"Kv2.1-Kv6.4 subunits deficiency impairs inhibitory signaling and visual circuit dynamics in zebrafish","date":"2025-10-31","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.30.685505","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.02.651974","title":"Loss of age-associated increase in m  <sup>6</sup>  A-modified RNA contributes to GABAergic dysregulation in Alzheimer’s disease","date":"2025-05-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.02.651974","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.22.684016","title":"Proteomic characterization of neuronal extracellular vesicle interactomes in Alzheimer’s disease mouse model through TurboID-based proximity labeling","date":"2025-10-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.22.684016","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.09.632229","title":"MicroRNA-502-3p modulates the GABA A subunits, synaptic proteins and mitochondrial morphology in hippocampal neurons","date":"2025-01-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.09.632229","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.28.625971","title":"<i>GABRA1</i>  frameshift variants impair GABA  <sub>A</sub>  receptor proteostasis","date":"2024-11-29","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.28.625971","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.28.656556","title":"Prenatal alcohol exposure dysregulates the expression of clock genes and alters rhythmic behaviour in mice","date":"2025-05-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.28.656556","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.30.621141","title":"The persistent effects of predator odor stressor enhance interoceptive sensitivity to alcohol through GABA  <sub>A</sub>  receptor adaptations in the prelimbic cortex in male, but not female rats","date":"2024-10-31","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.30.621141","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":31405,"output_tokens":4003,"usd":0.07713,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11911,"output_tokens":4111,"usd":0.081165,"stage2_stop_reason":"end_turn"},"total_usd":0.158295,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"The Ala322Asp (A322D) missense mutation in GABRA1 (encoding the GABAA receptor α1 subunit) causes reduced amplitude of GABA-activated currents in vitro compared to wildtype receptors, indicating loss-of-function of this inhibitory ligand-gated ion channel.\",\n      \"method\": \"In vitro electrophysiology (GABA-activated current recording in transfected cells expressing mutant vs. wildtype receptors)\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro functional assay with mutagenesis, single lab but clear electrophysiological readout establishing loss-of-function mechanism\",\n      \"pmids\": [\"11992121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The PTC-generating frameshift mutation 975delC (S326fs328X) in GABRA1 leads to substantial reduction of mutant α1 mRNA via nonsense-mediated mRNA decay (NMD) requiring intact ribosomes and the NMD-essential factor hUPF-1. A minor fraction of mRNA escapes NMD and produces truncated mutant protein, which undergoes endoplasmic reticulum-associated degradation (ERAD) with enhanced association with molecular chaperones.\",\n      \"method\": \"Minigene NMD assay, ribosome inhibition, siRNA knockdown of hUPF-1, protein stability assay, molecular chaperone co-immunoprecipitation in neurons and non-neuronal cells\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (NMD reporter, ribosome inhibition, gene silencing, ERAD assay, chaperone association) in a single rigorous study\",\n      \"pmids\": [\"19261879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Four selected GABRA1 mutations studied in the Xenopus laevis oocyte expression system revealed loss-of-function of the GABAA receptor, without a clear genotype-phenotype correlation.\",\n      \"method\": \"Two-electrode voltage clamp electrophysiology in Xenopus laevis oocytes expressing mutant GABRA1\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — functional electrophysiology in oocyte system, single lab, limited detail in abstract\",\n      \"pmids\": [\"27521439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"De novo GABRA1 mutations (P260S, L296S/W315L in transmembrane domains; R112Q, N115D in N-terminal GABA binding domain) cause reduced cell surface and total GABAA receptor expression, altered ER processing, impaired synaptic clustering, reduced GABAA receptor function, and decreased GABA binding potency in neuronal and non-neuronal cells.\",\n      \"method\": \"Next-generation sequencing, patch-clamp electrophysiology, surface biotinylation, immunofluorescence receptor clustering assay, flow cytometry in neuronal and non-neuronal cells\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (electrophysiology, surface expression, clustering, ER processing) in same study, single lab\",\n      \"pmids\": [\"31056671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The de novo GABRA1 R214C variant decreases whole-cell GABA-evoked currents by reducing single-channel open time and reducing both surface and total GABAA receptor expression. Verapamil treatment for 24 h fully restored function of mutant receptors primarily by increasing channel open time, while diazepam and insulin only partially restored currents.\",\n      \"method\": \"Whole-cell, outside-out macro-patch, and single-channel patch-clamp recordings; surface biotinylation assay; western blot in HEK cells expressing wildtype or mutant α1\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in HEK cells with multiple orthogonal patch-clamp configurations plus biochemical surface expression assays, single lab\",\n      \"pmids\": [\"31707987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A novel de novo GABRA1 variant p.(Ala332Val) in transmembrane domain helix 3 (TM3) leaves protein levels and cell surface trafficking unchanged but produces a significant left-shift of apparent GABA potency and changes in desensitization kinetics, as well as a left-shifted apparent diazepam potency in radioligand displacement assays — a gain-of-sensitivity (increased GABA potency) mechanism.\",\n      \"method\": \"Two-electrode voltage clamp electrophysiology, radioligand displacement assay, surface expression analysis in Xenopus oocytes or heterologous expression system\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous in vitro functional assays with multiple readouts, but single lab and single variant\",\n      \"pmids\": [\"32047208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Loss of gabra1 in zebrafish (morpholino knockdown) results in hypomotility and reduced expression of other GABAA receptor subunits. Expression of wildtype human GABRA1 partially rescued the hypomotility phenotype, whereas the c.875C>T variant failed to rescue, demonstrating that this is a loss-of-function allele.\",\n      \"method\": \"Zebrafish morpholino knockdown, behavioral analysis (swim patterns), rescue experiment with wildtype vs. mutant human GABRA1 mRNA injection\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with behavioral readout and rescue experiment, two orthogonal approaches, single lab\",\n      \"pmids\": [\"32205311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GABRA1 mutations associated with Dravet syndrome (L215P, R214C, V287I, R214H) cause defects in receptor gating as the common functional deficiency, with variant α1 subunits expressing well but being functionally impaired, indicating gating dysfunction rather than trafficking as the primary mechanism for α1 and β2 subunit Dravet variants.\",\n      \"method\": \"Patch-clamp electrophysiology, GABAA receptor biogenesis and trafficking assays in transfected cells\",\n      \"journal\": \"Brain communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — functional electrophysiology and biogenesis assays, single lab, abstracts do not detail full method depth\",\n      \"pmids\": [\"34095830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The GABRA1 α1(T292S) variant significantly increases GABA-evoked whole-cell currents and shifts dose-response curve leftward, increasing single-channel open time and open probability, demonstrating a gain-of-function at T292. In contrast, α1(T292I) decreases GABA-evoked currents, shifts dose-response rightward with severely diminished maximum, and decreases single-channel open time — demonstrating that T292 is a critical residue controlling GABAA receptor channel gating and that mutations at this residue can cause opposite gain- or loss-of-function effects.\",\n      \"method\": \"Whole-cell and single-channel patch-clamp recordings in HEK293 cells expressing wildtype or mutant rat recombinant GABAARs; biochemical analysis\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in HEK293 cells with whole-cell and single-channel patch-clamp, multiple mutants tested with opposite phenotypes establishing mechanistic residue function\",\n      \"pmids\": [\"35269865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Ethanol exposure reduces GABRA1 (α1 subunit) gene and protein expression in cultured cortical neurons through class I HDAC (HDAC1-3)-mediated histone deacetylation at the Gabra1 promoter. Pharmacological inhibition or knockdown of HDAC1-3 prevented ethanol-induced decreases in α1 expression. Targeted histone acetylation at the Gabra1 promoter using CRISPR dCas9-P300 prevented the decrease, while targeting P300 to a distant exon had no effect.\",\n      \"method\": \"CRISPR dCas9-P300 targeted histone acetylation, dCas9-KRAB repressor, HDAC inhibitor pharmacology, siRNA knockdown of HDAC1-3, qPCR and western blot in cultured cortical neurons\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (CRISPR epigenetic editing, pharmacology, genetic knockdown) in same study establishing promoter-level histone deacetylation mechanism\",\n      \"pmids\": [\"28798030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In chronic heart failure rats, JNK activation (downstream of prostaglandin E2/EP3 receptor signaling) reduces GABRA1 (and GAD1) expression in the paraventricular nucleus (PVN). JNK inhibitor SP600125 normalized sympathoexcitation and restored GAD1 and GABRA1 expression, while EP1, EP2, and EP4 receptor antagonists had no effect. PTGER3 agonist activated JNK and downregulated GABRA1 in NG108 neuronal cells.\",\n      \"method\": \"In vivo PVN infusion of receptor agonists/antagonists and JNK inhibitor in CHF rats, quantitative RT-PCR, western blot, immunofluorescence, renal sympathetic nerve discharge recordings, cell-based assays in NG108 neuronal cells\",\n      \"journal\": \"Acta physiologica (Oxford, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo pharmacological epistasis with multiple receptor-specific antagonists plus in vitro cell confirmation, single lab\",\n      \"pmids\": [\"27439062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Four clinical GABRA1 frameshift variants (K401fs, S326fs, V290fs, F272fs) — removing one to three transmembrane helices — all exhibit significantly reduced trafficking to the cell surface in HEK293T cells, resulting in essentially non-functional ion channels. They show ER retention and activate the unfolded protein response (UPR) to varying extents depending on which transmembrane domains are deleted, revealing overlapping yet distinct proteostasis impairment mechanisms.\",\n      \"method\": \"Surface trafficking assay, ER retention immunofluorescence, UPR activation assay, patch-clamp electrophysiology in HEK293T cells\",\n      \"journal\": \"bioRxiv : the preprint server for biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (trafficking, ER retention, UPR, electrophysiology) across four variants, single lab, preprint\",\n      \"pmids\": [\"39651292\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Loss of function of gabra1 in zebrafish (germline sa43718 nonsense allele) causes light-induced hypermotility (seizure-like behavior) and decreased mRNA expression of gabra2, gabra3, and gabra5. Proteomics revealed abnormal expression of proteins regulating synaptic vesicle fusion, vesicle transport, synapse development, and mitochondrial protein complexes.\",\n      \"method\": \"Germline zebrafish mutant (sa43718 allele), behavioral analysis, qRT-PCR, proteomics\",\n      \"journal\": \"Differentiation; research in biological diversity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with behavioral, transcriptional, and proteomic readouts, single lab\",\n      \"pmids\": [\"38908344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"4-Phenylbutyrate (PBA) increases both total and cell surface α1 (GABRA1) subunit expression for wildtype and A322D mutant subunits in HEK293T cells and in vivo in Gabra1+/A322D knockin mice (increased GABAA receptor expression in thalamus), identifying PBA-mediated proteostasis enhancement as a mechanism to rescue GABRA1 variant-associated receptor trafficking deficits.\",\n      \"method\": \"Flow cytometry, patch-clamp recordings, western blot, in silico structural modeling in HEK293T cells; in vivo thalamic GABAA receptor expression in Gabra1+/A322D knockin mice\",\n      \"journal\": \"bioRxiv : the preprint server for biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — multiple orthogonal methods in vitro and in vivo, single lab, preprint only\",\n      \"pmids\": [\"42239367\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Ectopic overexpression of GABRA1 in colon cancer cell lines resulted in strong inhibition of cell growth, suggesting a functional role in regulating cell proliferation in a non-neuronal context.\",\n      \"method\": \"Ectopic overexpression in colon cancer cell lines, cell growth assay\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single overexpression assay in cancer cell lines, single lab, no mechanistic pathway placement\",\n      \"pmids\": [\"22038115\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABRA1 encodes the α1 subunit of the GABAA receptor, a ligand-gated chloride channel mediating fast inhibitory neurotransmission; pathogenic mutations cause loss-of-function via reduced GABA-evoked currents (impaired channel gating or reduced single-channel open time), decreased cell surface expression through ER retention/ERAD and NMD of PTC-containing transcripts, or — for rare variants such as A332V — gain-of-sensitivity with increased GABA potency; transcription of GABRA1 is repressed by class I HDAC-mediated histone deacetylation at its promoter (e.g., downstream of ethanol or JNK/prostaglandin signaling), and multiple upstream miRNAs (miR-129-2-3p, miR-181a-5p, miR-502-3p) directly target GABRA1 mRNA to regulate its expression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GABRA1 encodes the α1 subunit of the GABAA receptor, a ligand-gated chloride channel that mediates fast inhibitory neurotransmission, and its disruption produces epileptic phenotypes through multiple convergent loss-of-function mechanisms [#0, #6]. Disease-associated missense and frameshift variants impair receptor function by distinct routes: some directly disrupt channel gating—reducing single-channel open time and GABA-evoked current amplitude while the subunit still expresses and traffics normally [#4, #7]—while others reduce cell-surface and total receptor levels through altered ER processing, ER retention, ERAD, and unfolded protein response activation, with frameshift/PTC transcripts additionally subject to nonsense-mediated decay [#1, #3, #11]. The transmembrane residue T292 is a critical determinant of gating, where different substitutions produce opposite gain- or loss-of-function effects [#8], and rare variants such as A332V instead increase apparent GABA potency without altering trafficking, defining a gain-of-sensitivity mechanism [#5]. Beyond mutation, GABRA1 expression is repressed at its promoter by class I HDAC-mediated histone deacetylation downstream of ethanol exposure, and by JNK signaling downstream of prostaglandin E2/EP3 receptor activation [#9, #10]. Proteostasis-directed small molecules including verapamil and 4-phenylbutyrate can restore trafficking and function of variant receptors [#4, #13]. In vivo, loss of gabra1 causes motor and seizure-like behavioral phenotypes and downregulation of other GABAA receptor subunits, confirming its role in coordinated inhibitory receptor function [#6, #12].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established that a GABRA1 missense mutation directly impairs the inhibitory channel, defining a loss-of-function disease mechanism at the level of receptor current.\",\n      \"evidence\": \"In vitro electrophysiology of GABA-activated currents in transfected cells expressing mutant vs. wildtype α1\",\n      \"pmids\": [\"11992121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single variant; did not distinguish gating defect from trafficking deficit\", \"No in vivo confirmation\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed that PTC-generating frameshift alleles are eliminated by NMD and that escaping truncated protein is degraded by ERAD, explaining how such variants cause haploinsufficiency rather than dominant-negative toxicity.\",\n      \"evidence\": \"Minigene NMD assay, ribosome inhibition, hUPF-1 siRNA knockdown, ERAD/chaperone co-IP in neuronal and non-neuronal cells\",\n      \"pmids\": [\"19261879\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single frameshift variant studied\", \"Did not quantify residual surface receptor in vivo\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Tested multiple clinical variants in a common expression system, confirming loss-of-function as a recurrent theme but finding no clean genotype-phenotype correlation.\",\n      \"evidence\": \"Two-electrode voltage clamp in Xenopus oocytes\",\n      \"pmids\": [\"27521439\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Limited mechanistic resolution\", \"No surface expression or gating discrimination reported\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolved that distinct domains contribute to dysfunction—N-terminal binding-domain variants reduce GABA potency while transmembrane variants impair ER processing, surface expression, and synaptic clustering.\",\n      \"evidence\": \"Patch-clamp, surface biotinylation, clustering immunofluorescence, flow cytometry in neuronal and non-neuronal cells\",\n      \"pmids\": [\"31056671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not isolate single-channel gating parameters for all variants\", \"Synaptic effects inferred from clustering, not synaptic transmission\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated that a gating-class variant reducing single-channel open time can be pharmacologically rescued, providing a mechanistic rationale for proteostasis/channel-modulator therapy.\",\n      \"evidence\": \"Whole-cell, macro-patch, and single-channel patch-clamp plus surface biotinylation and western blot in HEK cells, with verapamil/diazepam/insulin treatment\",\n      \"pmids\": [\"31707987\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Rescue shown in HEK cells, not in neurons or in vivo\", \"Single variant\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified a gain-of-sensitivity mechanism, showing that a TM3 variant increases GABA potency without trafficking change, expanding the variant mechanism spectrum beyond loss-of-function.\",\n      \"evidence\": \"Two-electrode voltage clamp, radioligand displacement, surface expression analysis\",\n      \"pmids\": [\"32047208\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single variant\", \"In vivo consequence of increased potency not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Provided in vivo validation that a clinical variant is a loss-of-function allele, since wildtype but not variant human GABRA1 rescued knockdown phenotypes.\",\n      \"evidence\": \"Zebrafish morpholino knockdown with behavioral analysis and wildtype/mutant rescue\",\n      \"pmids\": [\"32205311\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Morpholino knockdown subject to off-target concerns\", \"Single variant tested in rescue\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established that for a set of Dravet-associated α1 variants gating dysfunction—not trafficking—is the common functional deficit, since variant subunits expressed well but were impaired.\",\n      \"evidence\": \"Patch-clamp and biogenesis/trafficking assays in transfected cells\",\n      \"pmids\": [\"34095830\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Method depth limited in report\", \"Did not reconcile with trafficking-deficient variants from other studies\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Pinpointed T292 as a critical gating residue by showing opposite gain- and loss-of-function effects of different substitutions on single-channel open time and probability.\",\n      \"evidence\": \"Whole-cell and single-channel patch-clamp in HEK293 cells expressing recombinant GABAARs\",\n      \"pmids\": [\"35269865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of opposite effects not directly resolved\", \"Clinical correlation of T292 variants not established here\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Linked frameshift variants removing transmembrane helices to ER retention and graded UPR activation, defining variant-specific proteostasis impairment as a mechanism of channel loss.\",\n      \"evidence\": \"Surface trafficking, ER retention immunofluorescence, UPR activation, patch-clamp in HEK293T cells (preprint)\",\n      \"pmids\": [\"39651292\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not peer-reviewed\", \"Conducted in non-neuronal HEK293T cells only\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined a transcriptional/epigenetic regulatory axis showing that class I HDAC-mediated histone deacetylation at the Gabra1 promoter represses expression downstream of ethanol.\",\n      \"evidence\": \"CRISPR dCas9-P300/KRAB epigenetic editing, HDAC inhibitor pharmacology, HDAC1-3 siRNA, qPCR/western in cortical neurons\",\n      \"pmids\": [\"28798030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking ethanol to HDAC recruitment not fully resolved\", \"In vivo behavioral consequence not tested here\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed that prostaglandin E2/EP3-driven JNK signaling downregulates GABRA1 in the paraventricular nucleus, linking receptor expression to sympathoexcitation in heart failure.\",\n      \"evidence\": \"In vivo PVN pharmacology with receptor-specific antagonists and JNK inhibitor, RT-PCR, western, nerve recordings, NG108 cell assays\",\n      \"pmids\": [\"27439062\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional target of JNK at Gabra1 promoter not defined\", \"Correlative expression changes\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Provided germline genetic in vivo evidence that gabra1 loss causes seizure-like behavior and coordinately downregulates other GABAA subunits, with broad synaptic/proteomic remodeling.\",\n      \"evidence\": \"Germline zebrafish nonsense mutant, behavioral analysis, qRT-PCR, proteomics\",\n      \"pmids\": [\"38908344\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Proteomic changes are associative, not mechanistically dissected\", \"Single model organism\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Demonstrated that the proteostasis enhancer 4-phenylbutyrate restores surface expression of trafficking-deficient variant receptors in vitro and in a knockin mouse, supporting a therapeutic strategy.\",\n      \"evidence\": \"Flow cytometry, patch-clamp, western, in silico modeling in HEK293T cells; thalamic receptor expression in Gabra1+/A322D knockin mice (preprint)\",\n      \"pmids\": [\"42239367\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not peer-reviewed\", \"Functional/behavioral rescue in mice not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the distinct variant classes (gating-impaired, trafficking-deficient, gain-of-sensitivity) map onto specific clinical phenotypes, and whether epigenetic/miRNA and proteostasis-directed interventions translate to in vivo seizure rescue, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified genotype-phenotype framework across variant mechanisms\", \"Therapeutic rescue largely in vitro or preprint-stage\", \"Non-neuronal proliferative role uncharacterized mechanistically\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 4, 8]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 3, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 4, 11]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 3, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 6, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"complexes\": [\"GABAA receptor\"],\n    \"partners\": [\"GABRA2\", \"GABRA3\", \"GABRA5\", \"GABRB2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}